Progesterone Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Progesterone Market is segmented by Product Type (Natural and Synthetic Progesterone), Mode of Delivery, Application, and Geography.

Progesterone Market Snapshot

 progesterone market size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 13.1 %
 progesterone market key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The progesterone market is expected to record a CAGR of 13.1% over the forecast period. 

  • Rising incidences of disorders, such as abnormal uterine bleeding and amenorrhea, and the female population suffering from these diseases, are expected to promote growth. According to the study of “Amenorrhea, Secondary”, in the US, approximately 5% of menstruating women experience 3 months of secondary amenorrhea, each year.
  • Menopausal females form the largest section of the market. Hence, the growing range of menopausal windows and the rising female population in the age group of 45-59 years are expected to further bolster the overall market growth.
  • In addition, an upsurge in the incidence of breast cancer in women is anticipated to be a key growth factor, as the patient pool of breast cancer may suffer from breast tenderness, where the progesterone hormone is considered as one of the treatment options. Hence, the usage of progesterone is anticipated to increase. As per the World Health Organization, breast cancer ranks as the fifth leading cause of death in women, impacting 2.1 million women, each year, thus, driving the market studied.
  • The growing demand for progesterone is driven by the presence of routinely monitored formulations, technological advancements in the field of drug delivery systems, and increasing awareness among patients.
  • The wide range of pipeline drugs possessing high probability of approval in clinical trials in the future is predicted to provide lucrative growth opportunities to the progesterone market. Some imperative investigational drugs include DARE-HRT1, Onapristone, and VOLT02.
  • However, the lack of awareness regarding the availability of the progesterone therapy in developing regions and side effects of the therapy may restrict the market.

Scope of the Report

The scope of the progesterone market is inclusive of the types of progesterone, delivery of the same, and their applications in various disease areas. The report also describes the geographical scenario of the market studied, in major regions, such as North America, Europe, Asia-Pacific, Middle-East and Africa, and South America.

Product Type
Natural Progesterone
Synthetic Progesterone
Mode of Delivery
Injectable
Suspended Form
Oral
Other Modes of Delivery
Application
Menopause
Dysfunctional Uterine Bleeding
Endometrial Cancer
Contraception
Hyperplastic Precursor Lesions
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Natural Progesterone Segment is Believed to Witness Healthy Growth

The product segment includes natural progesterone and synthetic progesterone. Natural progesterone-based products are inclusive of combination drug therapies made from soybeans or a wild, inedible Mexican yam called Diascorea villosa.

Natural progesterone is expected to witness lucrative growth during the forecast period. Natural progesterone-based products have been studied to generate the largest number of prescriptions. Drugs, such as Crinone and Prometrium, are the major contributors to revenue.

The high growth potential attained is a consequence of positive patient outcomes associated with natural progesterone. The positive patient outcomes can be attributed to significant improvements in hormonal interactions.

Hence, due to the significance of natural progesterone, the segment may witness rapid growth.

 progesterone market trends

North America Dominates the Market

North America is leading, owing to the presence of major market players. Several collaborative efforts undertaken by major companies to enhance their R&D capabilities and ensure high medical standards are anticipated to impel the demand across this region. Moreover, the majority share can also be attributed to the high disease burden in this region. Increasing cases of kidney, breast, or uterine cancer types and the rising population of menopausal women are the key drivers of the market in the region.

Asia-Pacific is expected to witness the fastest growth over the forecast period. Increasing awareness levels and the rising focus of healthcare providers on the eradication of hormonal deficiencies are expected to boost the market growth within the region. Similar trends are expected to be observed in developing countries, such as South Africa.

 progesterone market growth rate

Competitive Landscape

The major market players include companies, such Alkem Labs, Aquatic Remedies Pvt. Ltd, Bionpharma, Blubellpharma, Cadila Pharmaceuticals, Cipla Limited, Estrellas Life Sciences Private Limited, Glenmark Limited, Lupin, Mankind Pharma, and Virtus.

Investment in the development of effective and long-acting products, with lesser adverse effects, and improving geographical penetration through partnerships and collaborations are the key strategies adopted by the companies to increase their market shares. For instance, in December 2019, Mankind Pharma launched the generic Dydrogesterone tablets for treatment of infertility and pregnancy-related complications in the Indian market. This was carried out to expand the treatment options and gain competitive advantage.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Incidence of Amenorrhea and Uterine Dying

      2. 4.2.2 Increase in Cases of Female Infertility and Breast Cancer

      3. 4.2.3 Technological Advancements in the Medical Industry

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness Regarding the Availability of Hormone Therapy

      2. 4.3.2 Side Effects of Progesterone

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product Type

      1. 5.1.1 Natural Progesterone

      2. 5.1.2 Synthetic Progesterone

    2. 5.2 Mode of Delivery

      1. 5.2.1 Injectable

      2. 5.2.2 Suspended Form

      3. 5.2.3 Oral

      4. 5.2.4 Other Modes of Delivery

    3. 5.3 Application

      1. 5.3.1 Menopause

      2. 5.3.2 Dysfunctional Uterine Bleeding

      3. 5.3.3 Endometrial Cancer

      4. 5.3.4 Contraception

      5. 5.3.5 Hyperplastic Precursor Lesions

      6. 5.3.6 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alkem Labs

      2. 6.1.2 Aquatic Remedies Pvt. Ltd

      3. 6.1.3 Bionpharma

      4. 6.1.4 Blubellpharma

      5. 6.1.5 Cadila Pharmaceuticals

      6. 6.1.6 Cipla Limited

      7. 6.1.7 Estrellas Life Sciences Private Limited

      8. 6.1.8 Glenmark Pharmaceuticals

      9. 6.1.9 Lupin Limited

      10. 6.1.10 Virtus

      11. 6.1.11 Teva Pharmaceuticals

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Progesterone Market market is studied from 2018 - 2026.

The Progesterone Market is growing at a CAGR of 13.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Cadila Pharmaceuticals , Alkem Labs , Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals are the major companies operating in Progesterone Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!